glp-1 agonists and inflammation Frontiers Frontiers | GLP-1 receptor agonists

A.SinghL.SinghG.RaufmanJ

Ward CW, Menting JG, Lawrence MC

Drugs in this class In the UK, the following incretin mimetics are available for type 2 diabetic patients (trade name first, generic name in brackets): Bydureon (Exenatide) taken once weekly Byetta (Exenatide) taken twice daily Lyxumia (lixisenatide) taken once daily Trulicity (Dulaglutide) taken once weekly Victoza (Liraglutide) taken once daily Ozempic (Semaglutide) take once a week Byetta and Bydureon are the same medical drug

First, the treatment sequence and interaction term between the trial arm and sequence were included to account for a carryover effect of the study drug

It is marked by high blood glucose levels and the presence of both microvascular and macrovascular complications, which significantly add to increased morbidity and death rates associated with the disease